Tiny implant could spare men from harsh hormone therapy
NCT ID NCT04943536
Summary
This study is testing a new type of implant that slowly releases a cancer-fighting drug directly into the prostate. The goal is to see if this local treatment can replace the standard body-wide hormone therapy, which often causes difficult side effects. The study will check if the implant is safe and well-tolerated when used alongside radiation therapy in men with localized prostate cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cancer Institute
Bethesda, Maryland, 20894, United States
Conditions
Explore the condition pages connected to this study.